Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Laughlin

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Bone Marrow Transplantation|May 4, 2010
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registriesY C Cohen, A Scaradavou, C E Stevens, et al.
Bone Marrow Transplantation|June 5, 1998
Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemiaM L Graham, B L Asselin, J E Herndon, et al.
Vox Sanguinis|August 31, 2002
International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantationC P Engelfriet, H W Reesink, J E Wagner, et al.
Bone Marrow Transplantation|October 18, 2011
Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignanciesT L Kindwall-Keller, Y Hegerfeldt, H J Meyerson, et al.
Blood|August 15, 2000
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remissionM S Tallman, P A Rowlings, G Milone, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Bone Marrow Transplantation|May 4, 2010
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registriesY C Cohen, A Scaradavou, C E Stevens, et al.
Bone Marrow Transplantation|June 5, 1998
Toxicity, pharmacology and feasibility of administration of PEG-L-asparaginase as consolidation therapy in patients undergoing bone marrow transplantation for acute lymphoblastic leukemiaM L Graham, B L Asselin, J E Herndon, et al.
Vox Sanguinis|August 31, 2002
International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantationC P Engelfriet, H W Reesink, J E Wagner, et al.
Bone Marrow Transplantation|October 18, 2011
Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignanciesT L Kindwall-Keller, Y Hegerfeldt, H J Meyerson, et al.
Blood|August 15, 2000
Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remissionM S Tallman, P A Rowlings, G Milone, et al.
Pageof 4